Mirko Trilling researcher
Trilling, Mirko
VIAF ID: 21157413797616052619 (Personal)
Permalink: http://viaf.org/viaf/21157413797616052619
Preferred Forms
- 100 0 _ ‡a Mirko Trilling ‡c researcher
- 100 1 _ ‡a Trilling, Mirko
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
An A/U-Rich Enhancer Region Is Required for High-Level Protein Secretion through the HlyA Type I Secretion System. | |
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions | |
"Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells | |
Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses. | |
Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes | |
Broad and potent antiviral activity of the NAE inhibitor MLN4924. | |
c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication | |
The Canonical Immediate Early 3 Gene Product pIE611 of Mouse Cytomegalovirus Is Dispensable for Viral Replication but Mediates Transcriptional and Posttranscriptional Regulation of Viral Gene Products | |
CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection | |
CD4+ T cells develop antiretroviral cytotoxic activity in the absence of regulatory T cells and CD8+ T cells | |
Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses | |
Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies | |
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology | |
The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling | |
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses | |
Data-warehousing of protein-protein interactions indicates that pathogens preferentially target hub and bottleneck proteins | |
Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression | |
Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis. | |
Deletion of the non-adjacent genes UL148 and UL148D impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation | |
A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus | |
The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients. | |
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus | |
Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization | |
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts | |
Genome Plasticity of Herpesviruses: Conservative yet Flexible | |
Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1 | |
Highly individual patterns of virus-immune IgG effector responses in humans | |
Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III | |
Human Cytomegalovirus-Induced Degradation of CYTIP Modulates Dendritic Cell Adhesion and Migration | |
Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation | |
human cytomegalovirus pUL145 isoforms act as viral DDB1-cullin-associated factors to instruct host protein degradation to impede innate immunity | |
Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells | |
Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients | |
Important scaffold function of the Janus kinase 2 uncovered by a novel mouse model harboring a Jak2 activation-loop mutation | |
Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection | |
Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo | |
Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention | |
The interplay between emerging human coronavirus infections and autophagy | |
M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells | |
m6A modification controls the innate immune response to infection by targeting type I interferons | |
MAPKAP kinase 2 regulates IL-10 expression and prevents formation of intrahepatic myeloid cell aggregates during cytomegalovirus infections | |
A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded Vpx | |
Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus | |
An MCMV mutant lacking the IFN antagonist pM27 elicits strong humoral immune responses and can serve as a live attenuated vaccine | |
Mouse cytomegalovirus inhibits beta interferon (IFN- ) gene expression and controls activation pathways of the IFN- enhanceosome | |
Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system | |
A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors | |
Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus. | |
Over 90% of clinical swabs used for SARS-CoV-2 diagnostics contain sufficient nucleic acid concentrations | |
Prophylactic and Therapeutic HBV Vaccination by an HBs-expressing Cytomegalovirus Vector Lacking an Interferon Antagonist in Mice | |
Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation | |
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19 | |
STAT2-dependent immune responses ensure host survival despite the presence of a potent viral antagonist. | |
Structural mechanism of CRL4‐instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor | |
Susceptibility of HLA-E*01:03 allele carriers to develop Cytomegalovirus replication after living-donor kidney transplantation. | |
Tiza–Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study | |
TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection | |
The Transcription and Translation Landscapes during Human Cytomegalovirus Infection Reveal Novel Host-Pathogen Interactions |